Efficacy, safety, and cost-minimization analysis of axicabtagene ciloleucel and tisagenlecleucel CAR T-Cell therapies for treatment of relapsed or refractory follicular lymphoma

Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are chimeric antigen receptor (CAR) T-cell therapies used to treat adult patients with relapsed or refractory follicular lymphoma (rrFL) after two or more lines of systemic therapy. In the absence of head-to-head clinical trials, this...

Descripción completa

Detalles Bibliográficos
Autor principal: Ghanem, Buthainah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560186/
https://www.ncbi.nlm.nih.gov/pubmed/37572232
http://dx.doi.org/10.1007/s10637-023-01389-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560186/
https://www.ncbi.nlm.nih.gov/pubmed/37572232
http://dx.doi.org/10.1007/s10637-023-01389-w

Ejemplares similares